CDY
Cellmid
- Short interest
- 0.02%
- −0.07 pp 30d
- as of 8 Dec 2017
- Reported shorts
- 13.3K
- Shares on issue
- 53.423M
Cellmid (CDY) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for CDY (last checked 15 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- AN1 - Appendix 4C & Activity Report for Q3 FY2026Quarterly Report27 Apr 2026via asx_announcements
- Appendix 4D 1H FY26 DEC 2025Half Year Results25 Feb 2026via asx_announcements
- Appendix 4C & Activity Report for Q2 FY2026Quarterly Report29 Jan 2026via asx_announcements
- Appendix 4C & Activity Report for Q1 FY2026Quarterly Report31 Oct 2025via asx_announcements
- AN1 2025 Annual ReportAnnual Report28 Aug 2025via asx_announcements
- Activity Report & Appendix 4C Q4 FY2025Quarterly Report28 Jul 2025via asx_announcements
- Appendix 4C Cash Flow ReportQuarterly Report1 May 2025via asx_announcements
- AN1 - Appendix 4D 1H FY2025Half Year Results27 Feb 2025via asx_announcements
- Anagenics - 1H FY25 Half Year ReportHalf Year Results27 Feb 2025via asx_announcements
- Q2 F25 Activity Statement and Appendix 4CQuarterly Report31 Jan 2025via asx_announcements
Showing 10 of 17 reports